IL5 and breast cancer: Our findings demonstrate that the group 2 innate lymphoid cells (ILC2s)‐myeloid‐derived suppressor cells (MDSCs) axis is associated with the unfavorable prognosis of advanced breast cancer in obese patients, and cytokine interleukin‐5 (IL‐5) may be involved in this process.